R
Radiopharm Theranostics Ltd
NASDAQ:RADX
Radiopharm Theranostics Ltd
NASDAQ:RADX
Price:
5.04
USD
-1.56%
Market Closed
Market Cap:
$11.8B
Balance Sheet
Balance Sheet Decomposition
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Balance Sheet Decomposition is not available for
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Balance Sheet
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Currency: AUD
| Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
27
|
12
|
19
|
29
|
|
| Cash |
0
|
27
|
12
|
19
|
29
|
|
| Total Receivables |
0
|
0
|
4
|
1
|
10
|
|
| Accounts Receivables |
0
|
0
|
4
|
1
|
10
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
3
|
0
|
|
| Total Current Assets |
0
|
27
|
16
|
23
|
40
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
56
|
59
|
49
|
47
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
83
+249 545%
|
75
-10%
|
72
-4%
|
86
+20%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
3
|
9
|
7
|
|
| Accrued Liabilities |
0
|
1
|
2
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
6
|
8
|
6
|
5
|
|
| Total Current Liabilities |
0
|
8
|
13
|
18
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
1
|
1
|
2
|
|
| Other Liabilities |
0
|
13
|
16
|
27
|
29
|
|
| Total Liabilities |
0
N/A
|
20
+12 815%
|
31
+50%
|
44
+44%
|
42
-5%
|
|
| Equity | ||||||
| Common Stock |
0
|
87
|
97
|
101
|
177
|
|
| Retained Earnings |
0
|
24
|
55
|
73
|
133
|
|
| Other Equity |
0
|
0
|
2
|
1
|
1
|
|
| Total Equity |
0
N/A
|
63
N/A
|
44
-30%
|
28
-37%
|
45
+59%
|
|
| Total Liabilities & Equity |
0
N/A
|
83
+249 545%
|
75
-10%
|
72
-4%
|
86
+20%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
277
|
280
|
359
|
460
|
2 365
|
|
Switch to:
Switch to:
See Also
Discover More
